Positive recommendation based on phase II NOBILITY and phase III REGENCY data showing Gazyva/Gazyvaro’s superiority over standard therapy alone1,2Gazyva/Gazyvaro is the only anti-CD20 antibody to ...

Positive recommendation based on phase II NOBILITY and phase III REGENCY data showing Gazyva/Gazyvaro's superiority over standard therapy alone1,2 Gazyva/Gazyvaro is the only anti-CD20 antibody to ...

The ORIGIN Phase 3 trial met the primary endpoint with a statistically significant and clinically meaningful reduction in proteinuria at week 36, in the prespecified interim analysis. Across the ...

(Alliance News) - AstraZeneca PLC on Friday said Saphnelo subcutaneous self-administration has been recommended for approval in the European Union for systemic lupus erythematosus.

XORTX Therapeutics Inc. (“XORTX ” or the “Company ”) (NASDAQ: XRTX \| TSXV: XRTX \| Frankfurt: ANU), a late stage clinica ...

The stock is trading at $5.69, up 2.92, gaining 105.40% on volume of over 61 Million shares. The stock had a morning high of ...

During a meeting this week, an expert panel of the EU drug regulator, the European Medicines Agency (EMA), has endorsed two ...

The combination of Lenvima (lenvatinib) and Keytruda (pembrolizumab) with chemotherapy did not help patients with metastatic ...

Lenvatinib plus pembrolizumab and chemotherapy did not significantly improve overall survival in metastatic ESCC compared to pembrolizumab and chemotherapy alone. Median overall survival was 17.6 ...

Novartis Fabhalta meets phase III primary endpoint, slows kidney function decline in patients with IgA nephropathy: Basel Friday, October 17, 2025, 10:00 Hrs [IST] Novartis announ ...

Prioritization of refractory rheumatoid arthritis (RA) as lead indication for AlloNK® development FDA Fast Track Designation received for AlloNK in refractory RA, representing the first drug candidate ...

Washington — Much of the federal government shut down Wednesday, October 1, after Congress failed to reach a deal to approve new funding. Republicans had proposed extending government funding at ...